Country Risk Associated with Overseas Expansion in Asia
First written in FY2017. 17 of 18 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2025: 50 of 94 companies on the "Worse" side.
78 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「The healthcare business operated by our group has expanded into Asia, and the group's results and other matters may be affected by country risks in those countries, including deterioration in political and economic conditions, unexpected changes in laws and regulations, and deterioration in public safety.」
The company continues to disclose the political and economic, legal and regulatory, and public safety risks associated with expanding its healthcare business into Asia. - FY2023RestatedAnnual report
「The healthcare business operated by our group has expanded into Asia, and the group's results and other matters may be affected by country risks in those countries, including deterioration in political and economic conditions, unexpected changes in laws and regulations, and deterioration in public safety.」
The company continues to disclose the political and economic, legal and regulatory, and public safety risks associated with expanding its healthcare business into Asia. - FY2023-Q3RestatedAnnual report
「During the third quarter of the consolidated cumulative period, there were no new business or other risks and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes in the country risks associated with overseas expansion in Asia. - FY2022-Q3RestatedAnnual report
「During the third quarter of the consolidated cumulative period, there were no new business or other risks and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes in the country risks associated with overseas expansion in Asia. - FY2021RestatedAnnual report
「The healthcare business operated by our group has expanded into Asia, and the group's results and other matters may be affected by country risks in those countries, including deterioration in political and economic conditions, unexpected changes in laws and regulations, and deterioration in public safety.」
The company continues to disclose the political and economic, legal and regulatory, and public safety risks associated with expanding its healthcare business into Asia. - FY2021-Q3RestatedAnnual report
「During the third quarter of the consolidated cumulative period, there were no new business or other risks and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes in the country risks associated with overseas expansion in Asia. - FY2021-Q2RestatedAnnual report
「During the second quarter of the consolidated cumulative period, there were no new business or other risks and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes in the country risks associated with overseas expansion in Asia. - FY2020RestatedAnnual report
「The healthcare business operated by our group has expanded into Asia, and the group's results may be affected by country risks in those countries, including deterioration in political and economic conditions, unexpected changes in laws and regulations, and deterioration in public safety.」
The company continues to disclose the political and economic, legal and regulatory, and public safety risks associated with expanding its healthcare business into Asia. - FY2020-Q3RestatedAnnual report
「During the third quarter of the consolidated cumulative period, there were no significant changes in the financial position, operating results or cash flows. There were also no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes in the country risks associated with overseas expansion in Asia. - FY2020-Q1RestatedAnnual report
「During the first quarter of the consolidated cumulative period, there were no new business or other risks and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes in the country risks associated with overseas expansion in Asia. - FY2019RestatedAnnual report
「The healthcare business operated by our group has expanded into Asia, and the group's results may be affected by country risks in those countries, including deterioration in political and economic conditions, unexpected changes in laws and regulations, and deterioration in public safety.」
The company continues to disclose the political and economic, legal and regulatory, and public safety risks associated with expanding its healthcare business into Asia. - FY2019-Q3RestatedAnnual report
「During the third quarter of the consolidated cumulative period, there were no significant changes in the financial position, operating results or cash flows. There were also no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company explains that there have been no material changes in the country risks associated with overseas expansion in Asia. - FY2019-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company explains that there have been no material changes in the country risks associated with overseas expansion in Asia. - FY2018RestatedAnnual report
「The healthcare business operated by our group has expanded into Asia, and the group's results may be affected by country risks in those countries, including deterioration in political and economic conditions, unexpected changes in laws and regulations, and deterioration in public safety.」
The company continues to disclose the political and economic, legal and regulatory, and public safety risks associated with expanding its healthcare business into Asia. - FY2018-Q3RestatedAnnual report
「There have been no material changes in the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company explains that there have been no material changes in the country risks associated with overseas expansion in Asia. - FY2018-Q2RestatedAnnual report
「There have been no material changes in the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company explains that there have been no material changes in the country risks associated with overseas expansion in Asia. - FY2018-Q1RestatedAnnual report
「There are no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company explains that there have been no material changes in the country risks associated with overseas expansion in Asia. - FY2017First statedAnnual report
「The healthcare business operated by our group has expanded into Asia, and the group's results may be affected by country risks in those countries, including deterioration in political and economic conditions, unexpected changes in laws and regulations, and deterioration in public safety.」
The company disclosed for the first time, as a separate item, the political and economic, legal and regulatory, and public safety risks associated with expanding its healthcare business into Asia.